Preferred Label : Ustekinumab;

MeSH definition : A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.;

CISMeF synonym : 1275, CNTO; CNTO1275;

MeSH hyponym : CNTO 1275; Stelara; CNTO-1275;

Wikipedia link : https://en.wikipedia.org/wiki/Ustekinumab;

Is substance : O;

UNII : FU77B4U5Z0;

Details


Main resources

You can consult :

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

https://www.ema.europa.eu/en/medicines/human/EPAR/absimky
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/imuldosa
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/eksunbi
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/wezenla
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/otulfi
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/fymskina
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
Ustekinumab
Ustekinumab
biosimilar pharmaceuticals

---
https://www.ema.europa.eu/en/medicines/human/EPAR/yesintek
2025
false
false
false
Netherlands
French
English
Ustekinumab
Ustekinumab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation

---
https://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvo
2024
false
false
false
Netherlands
French
English
drug approval
europe
Ustekinumab
Ustekinumab
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals

---
https://www.has-sante.fr/jcms/p_3539093/fr/stelara-ustekinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
Ustekinumab
chronic disease
biological therapy

---
https://www.ema.europa.eu/en/medicines/human/EPAR/steqeyma
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
injections, subcutaneous
biosimilar pharmaceuticals
Ustekinumab
Ustekinumab
arthritis, psoriatic
psoriasis
crohn disease
drug interactions
pregnancy
breast feeding
ustekinumab

---
https://assurance-maladie.ameli.fr/etudes-et-donnees/2024-vedolizumab-ustekinumab-anti-tnf-grossesse-mici
2024
France
scientific and technical information
safety
TNF Gene
Ustekinumab
inflammatory bowel disease, nos
tumor necrosis factor
Institutional Review Board Independent Ethics Committee Notification of Safety Information Documentation
Physically Feel in Bad Condition
tumor necrosis factors
Safety Report
Clinical Trial Notification of Safety or Other Trial Information Documentation
chronic disease, nos
Vedolizumab
research report
vedolizumab
disease
Tumor Necrosis Factor
anti-TNF
Ustekinumab
Chronic Disease
Pregnant People
inflammatory bowel diseases
vedolizumab
pregnancy, nos
albumin/globulin ratio
chronic disease
Gravida

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pyzchiva
2024
false
false
false
Netherlands
French
English
Ustekinumab
Ustekinumab
drug approval
europe
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals
ustekinumab
psoriasis
arthritis, psoriatic
drug interactions
pregnancy
breast feeding
crohn disease
colitis, ulcerative
Product containing only ustekinumab in parenteral dose form (medicinal product form)
infusions, intravenous
Interleukin Inhibitors
Interleukin Inhibitors
Interleukin-12
Interleukin-23
injections, subcutaneous

---
https://www.has-sante.fr/jcms/p_3426151/fr/stelara-ustekinumab-psoriasis-en-plaques-chez-l-enfant-et-l-adolescent
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
ustekinumab
injections, subcutaneous
Interleukin Inhibitors
evaluation of the transparency committee
child
adolescent
Ustekinumab
psoriasis

---
https://www.has-sante.fr/jcms/p_3473772/fr/stelara-ustekinumab-psoriasis-en-plaques-rhumatisme-psoriasique-maladie-de-crohn-rectocolite-hemorragique
2023
false
false
false
France
psoriasis
adult
Interleukin Inhibitors
ustekinumab
injections, subcutaneous
Pen
evaluation of the transparency committee
Ustekinumab
colitis, ulcerative
crohn disease
arthritis, psoriatic

---
https://www.has-sante.fr/jcms/p_3270039/fr/stelara-ustekinumab-psoriasis
2021
false
false
false
France
adult
insurance, health, reimbursement
ustekinumab
evaluation of the transparency committee
Ustekinumab
psoriasis
treatment outcome

---
https://www.has-sante.fr/jcms/p_3201471
2020
France
evaluation of the transparency committee
Child
Child
Child
child, nos
child
Ustekinumab
Stelara
Child

---
https://www.has-sante.fr/jcms/p_3196694/fr/stelara-rch
2020
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
Ustekinumab
Ustekinumab
adult
colitis, ulcerative
ustekinumab
injections

---
https://www.cochrane.org/fr/CD012804/ustekinumab-et-briakinumab-pour-le-traitement-de-la-maladie-de-crohn-inactive
2019
France
United Kingdom
review of literature
french abstract
crohn disease
Diseases
briakinumab
Disease
Ustekinumab
crohn's disease, nos
antibodies, monoclonal

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42496
2017
false
false
false
France
French
crohn disease
legislation
vedolizumab
Ustekinumab
insurance, health, reimbursement
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/portail/jcms/c_2751848/fr/stelara
https://www.has-sante.fr/portail/jcms/c_2751848/fr/stelara-ustekinumab-immunosuppresseur-inhibiteur-des-interleukines
2017
false
France
French
Ustekinumab
psoriasis
treatment outcome
guidelines for drug use
child
arthritis, psoriatic
crohn disease
insurance, health, reimbursement
Interleukin-12
Interleukin-23
injections, subcutaneous
adult
ustekinumab
evaluation of the transparency committee

---
http://www.cri-net.com/fiches-pratiques-et-recommandations/prise-encharge-ustekinumab
2016
false
false
false
France
French
consensus
guidelines for drug use
patient care management
Off-Label use
Ustekinumab
Ustekinumab
ustekinumab
Interleukin-12
Interleukin-23
Evidence-Based medicine
continuity of patient care
crohn disease
psoriasis
arthritis, psoriatic
spondylarthropathies
Non-radiographic axial spondyloarthritis
Axial spondyloarthritis
injections, subcutaneous
pregnancy
vaccination
aged
surgical procedures, operative
adult
dialysis
splenectomy
practice guideline
patients guideline

---
http://www.has-sante.fr/portail/jcms/c_2621474/fr/stelara
2016
false
France
French
Ustekinumab
psoriasis
treatment outcome
Interleukin-12
Interleukin-23
injections, subcutaneous
adult
ustekinumab
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2621480/fr/stelara
http://www.has-sante.fr/portail/jcms/c_2621480/fr/stelara-ustekinumab-immunosuppresseur-inhibiteur-d-interleukine
2016
false
France
French
Ustekinumab
adolescent
psoriasis
dermatologic agents
treatment outcome
Interleukin-12
Interleukin-23
injections, subcutaneous
ustekinumab
guidelines for drug use
evaluation of the transparency committee

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/42613a-fra.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/42619a-fra.php
2014
false
false
false
Canada
French
English
pharmacovigilance note
patient education handout
ustekinumab
dermatitis, exfoliative
Erythrodermic psoriasis
psoriasis
adult
arthritis, psoriatic
risk
continuity of patient care
drug monitoring
Ustekinumab

---
http://www.has-sante.fr/portail/jcms/c_1792833/fr/stelara-ustekinumab-inhibiteur-des-interleukines-il-12-et-il-23
2014
false
France
French
arthritis, psoriatic
treatment outcome
Ustekinumab
Interleukin-12
Interleukin-23
injections, subcutaneous
adult
ustekinumab
guidelines for drug use
evaluation of the transparency committee

---
https://www.ema.europa.eu/medicines/human/EPAR/Stelara
2012
false
United Kingdom
English
French
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
syndication feed
Ustekinumab
Ustekinumab
treatment outcome
drug approval
psoriasis
adult
injections, subcutaneous
Interleukin-12
Interleukin-23
pharmaceutical solutions
drug interactions
pregnancy
breast feeding
drug evaluation
drug evaluation, preclinical
ustekinumab
antibodies, monoclonal
drug evaluation
summary of product characteristics
package leaflet

---
http://www.meddispar.fr/Medicaments/STELARA-90-B-1/(type)/letter/(value)/S/(cip)/3400937484954
2012
false
France
French
drug information
Ustekinumab
ustekinumab
legislation, drug
drug prescriptions
psoriasis
injections, subcutaneous

---
http://www.meddispar.fr/Medicaments/STELARA-45-B-1/(type)/letter/(value)/S/(cip)/3400937484893
2011
false
France
French
drug information
Ustekinumab
legislation, drug
drug prescriptions
injections, subcutaneous
psoriasis
ustekinumab

---
http://www.has-sante.fr/portail/jcms/c_841965/stelara-ustekinumab-inhibiteur-des-interleukines-il12-et-il23
2009
false
France
French
Ustekinumab
psoriasis
Interleukin-12
Interleukin-23
injections, subcutaneous
adult
ustekinumab
guidelines for drug use
evaluation of the transparency committee

---
Nous contacter.
05/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.